SlideShare une entreprise Scribd logo
1  sur  28
Name: Jon Jyoti Sahariah
B.Pharm 6th Sem
Roll No: 05
Year: 2017
Department of Pharmaceutical Sciences
Dibrugarh university
General term for those nutrients, including iron, folic
acid, and vitamin B12, required for the formation and
development of blood cells in bone marrow (the process of
haematopoiesis), deficiency of which may result in
anaemia.
Treatment of anemia
Increase the number of RBC or hemoglobin content of
RBC or both when there is deficiency
Main Haematinics are:
1.Iron
2.Vit-B12
3. Folic acid
Aneamia
 Not a single disease
 Results from a number of different pathologies
 Defined as a reduction from the normal quantity of Hb in
blood
 WHO defines anemia as Hb levels less than 13 g/dl for
males and less than 12 g/dl for females
 Low Hb levels results in decreased oxygen carrying
capacity of blood
 Causes:
 Blood loss
 Impaired RBC functions due to deficiency
Iron As Haematinic Agent
 Hematopoiesis
 The production of circulating erythrocytes, leukocytes and
platelets from undifferentiated stem cells, is called
hematopoiesis.
 It requires:
 Iron –for Hb formation
Iron storage
 Iron is the integral component of haemoglobin In our
body:
 66-67% of iron is present in hemoglobin.
 3% occurs in myoglobin
 1% in enzymes -cytochrome, catalase, peroxidase
 25% is stored in form of ferritin and hemosiderin
Pharmacokinetics :
Absorption:
 absorbs 5–10% of iron ingested or about 0.5–1 mg daily.
 normally absorbed in the duodenum and proximal
jejunum.
 absorption increases in response to low iron stores or
increased iron requirements.
STORAGE
 primarily as ferritin, in macrophages in the liver, spleen,
and bone, and in parenchymal liver cells. Apoferritin
synthesis is regulated by the levels of free iron.
 Ferritin is detectable in serum. Since the ferritin present in
serum is in equilibrium with storage ferritin in
reticuloendothelial tissues, the serum ferritin level can be
used to estimate total body iron stores.
Transport:
 transported in the plasma bound to transferrin, a -globulin
that specifically binds two molecules of ferrous iron The
transferrin-iron complex enters maturing erythroid cells by a
specific receptor mechanism. Transferrin receptors
internalize the transferrin-iron complex through the process
of receptor-mediated endocytosis.
 Increased erythropoiesis is associated with an increase in the
number of transferrin receptors on developing erythroid
cells. Iron store depletion and iron deficiency anemia are
associated with an increased concentration of serum
transferrin.
ELIMINATION
 Small amounts are lost in the feces by exfoliation of
intestinal mucosal cells, and trace amounts are excreted in
bile, urine, and sweat.
Indications of oral iron therapy
Prophylactic use :
1) pregnancy- from 4th month to lactation.
2) Menstruation
3) Infancy and childhood
4) Premature babies and babies weaned late
5) Professional blood donors
 Therapeutic use :
1) Iron deficiency anemia
2) Iron deficiency anemia due to:
- menorrhagia
- peptic ulcer
- piles
- hook worm infestation
3) Malabsorption syndrome
4) Anemia of pregnancy
5) Treatment of severe pernicious anemia
Parenteral iron preparations:
 Iron dextran is a stable complex of ferric hydroxide and
low-molecular-weight dextran containing 50 mg of
elemental iron per milliliter of solution. It can be given by
deep intramuscular injection or by intravenous infusion,
although the intravenous route is used most commonly
 Headache, light-headedness, fever, arthralgias, nausea
and vomiting, back pain, flushing, urticaria,
bronchospasm, and rarely, anaphylaxis and death.
 Hypersensitivity reaction to the dextran component.
Hypersensitivity reactions may be delayed for 48–72
hours after administration.
 Anaphylactic reactions
 Iron-sucrose complex and iron sodium gluconate
complex only by the intravenous route.
 Sources :
Yeast, liver, green vegetables, Fruits, nuts and cereals
Daily requirements :
Adult: 50 mcg / day
Pregnant women : 100-200 mcg / day
Lactating women : 100-200 mcg / day
FOLIC ACID:
Pharmacokinetics :
 Route : oral , parenteral
 Absorption: from proximal jejunum
 Excretion: Folates are excreted in the urine and stool
and are also destroyed by catabolism
 folic acid deficiency and megaloblastic anemia can
develop within 1–6 months after the intake of folic acid
stops.
Pharmacodynamics:
 Functions :
Tetrahydrofolate cofactors participate in one-carbon
transfer reactions
1) DNA synthesis : cofactors for the synthesis of
purines and pyrimidines
2) Synthesis of thymidylic acid :
Enzyme thymidylate synthase catalyzes the transfer
of the one-carbon unit.
Causes of folic acid deficiency:
A) Nutritional ( major
causes)
1) poor intake due to
 old age
 Starvation
 Anorexia
2) gastrointestinal disease
 Partial gastrectomy
 Coeliac disease
 Crohn’s disease
B) Poor Utilisation:
1) Physiological
 pregnancy
 starvation
 prematurity
2) Pathological
 hemolytic disease with
excess RBC formation
 malignant disease with
increased cell turnover
 inflammatory disease
C) Malabsorption syndrome
D) Antifolate drugs :
 anticonvulsants ( phenytoin , primidone )
 methotrexate
 Pyrimethamine
 Trimethoprim
 Sulfonamides
Effects of folic acid deficiency
 Megaloblastic anemia
 Neural tube defect ( spina bifida ) in the foetus
High-risk patients:
 pregnant women
 patients with alcohol dependence,
 hemolytic anemia
 liver disease
 certain skin diseases
 patients on renal dialysis
Indications of folic acid:
1) Treat magaloblastic anemia due to folate deficiency
2) Pregnant women
3) Premature infants
4) Patients with hemolytic anemia
5) Liver disease
6) Chronic skin disease
7) Renal dialysis
8) With anti convulsant drugs
 Folic acid in large amounts may counteract the
antiepileptic effect of phenobarbital, phenytoin, and
primidone, and increase the frequency of seizures in
susceptible children
Liquid oral preparations and injectables in combination form
Given im
Dose
Therapeutic : 2-5 mg / day
Prophylactic : 0.5 mg / day
Preparations and doses of folic acid :
Vit B12
 consists of a porphyrin-like ring with a central cobalt atom
attached to a nucleotide.
 Deoxyadenosylcobalamin and methylcobalamin are the active
forms
 The chief dietary source of vitamin B12 is microbially derived
vitamin B12 in meat (especially liver), eggs, and dairy
products
 extrinsic factor
Pharmacokinetics
 stored, primarily in the liver, with an average adult having a
total vitamin B12 storage pool of 3000–5000 mcg
 normal daily requirements of vitamin B12 are only about 2 mcg
 is absorbed only after it complexes with intrinsic factor, a
glycoprotein secreted by the parietal cells of the gastric mucosa
 the intrinsic factor-vitamin B12 complex is subsequently
absorbed in the distal ileum by a highly specific receptor-
mediated transport system.
 Nutritional deficiency is rare but may be seen in strict
vegetarians after many years without meat, eggs, or dairy
products.
 vitamin B12 is transported to the various cells of the body
bound to a plasma glycoprotein, transcobalamin II
 Stored in liver
 Excreted through urine
Indications of Vit B12
a) Megaloblastic anemia
b) Neurologic syndrome associated with cobalamin
deficiency
c) Pernicious anemia
 Vitamin B12 for parenteral injection is available as
cyanocobalamin or hydroxocobalamin
 Administered im
 Initial therapy should consist of 100–1000 mcg of
vitamin B12
 Maintenance therapy consists of 100–1000 mcg
intramuscularly once a month for life
 neurologic abnormalities are present, maintenance
therapy injections should be given every 1–2 weeks for
6 months before switching to monthly injections
 oral doses of 1000 mcg of vitamin B12 daily are usually
sufficient to treat patients with pernicious anemia
Dose:
 In india both oral and injectables vit B12 is available
mostly or combination preparation along with other
vitamines, with or without iron.
1.Treatment and prophylaxis of vitamin B12 deficiency
(megaloblastic anemia)
2. Vit B12 injection in pernicious anemia (condition where
Vit B12 is not absorbed from the stomach)
Uses of vitamin B12
THANK YOU

Contenu connexe

Tendances

Tendances (20)

3.Diuretics
3.Diuretics3.Diuretics
3.Diuretics
 
Anterior pituitary hormone analogues & inhibitors
Anterior pituitary hormone analogues & inhibitorsAnterior pituitary hormone analogues & inhibitors
Anterior pituitary hormone analogues & inhibitors
 
Haematinics
HaematinicsHaematinics
Haematinics
 
4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugs4th unit thyroid and antithyroid drugs
4th unit thyroid and antithyroid drugs
 
Coagulant and anticoagulant
Coagulant and anticoagulantCoagulant and anticoagulant
Coagulant and anticoagulant
 
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agentsHaematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
 
Anti Arrhythmic Drugs
Anti Arrhythmic DrugsAnti Arrhythmic Drugs
Anti Arrhythmic Drugs
 
Chemistry of Anti Anginal Drugs by Professor Beubenz
Chemistry of Anti Anginal Drugs by Professor BeubenzChemistry of Anti Anginal Drugs by Professor Beubenz
Chemistry of Anti Anginal Drugs by Professor Beubenz
 
4th unit drugs acting on endocrine system
4th unit drugs acting on endocrine system4th unit drugs acting on endocrine system
4th unit drugs acting on endocrine system
 
3rd unit coagulant and anticoagulant ppt
3rd unit coagulant  and anticoagulant ppt3rd unit coagulant  and anticoagulant ppt
3rd unit coagulant and anticoagulant ppt
 
Coagulant and anti coagulant
Coagulant and anti coagulantCoagulant and anti coagulant
Coagulant and anti coagulant
 
Pharmacology of Diuretics
Pharmacology of DiureticsPharmacology of Diuretics
Pharmacology of Diuretics
 
Congestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistryCongestive heart failure (chf) medicinal chemistry
Congestive heart failure (chf) medicinal chemistry
 
Haematinics
HaematinicsHaematinics
Haematinics
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Hematinics
HematinicsHematinics
Hematinics
 
14.antianginal drugs
14.antianginal drugs 14.antianginal drugs
14.antianginal drugs
 
Corticosteroids- medicinal chemistry
Corticosteroids- medicinal chemistryCorticosteroids- medicinal chemistry
Corticosteroids- medicinal chemistry
 
2nd unit diuretics
2nd unit diuretics2nd unit diuretics
2nd unit diuretics
 
Potassium - sparing diuretics
Potassium - sparing diureticsPotassium - sparing diuretics
Potassium - sparing diuretics
 

Similaire à Hematinics

Anemia, Pharmacotherapeutics, PharmD, RGUHS
Anemia, Pharmacotherapeutics, PharmD, RGUHSAnemia, Pharmacotherapeutics, PharmD, RGUHS
Anemia, Pharmacotherapeutics, PharmD, RGUHS
Amar Prasad
 
Irion defitient and megaloblastic anemias
Irion defitient and megaloblastic anemiasIrion defitient and megaloblastic anemias
Irion defitient and megaloblastic anemias
Jasmine John
 
Pharmacology anemia and its treatment
Pharmacology   anemia and its treatmentPharmacology   anemia and its treatment
Pharmacology anemia and its treatment
MBBS IMS MSU
 
Megaloblastic Anaemia - Vit B12 deficiency
Megaloblastic Anaemia - Vit B12 deficiencyMegaloblastic Anaemia - Vit B12 deficiency
Megaloblastic Anaemia - Vit B12 deficiency
Shahin Hameed
 
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdfAgents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
buruknatanium
 

Similaire à Hematinics (20)

Hematinics
HematinicsHematinics
Hematinics
 
ANEMIAS.pptx
ANEMIAS.pptxANEMIAS.pptx
ANEMIAS.pptx
 
Hematinics
HematinicsHematinics
Hematinics
 
Hemetinics 5sem pharmacy
Hemetinics 5sem pharmacyHemetinics 5sem pharmacy
Hemetinics 5sem pharmacy
 
Anti anaemic drugs (1)
Anti anaemic drugs (1)Anti anaemic drugs (1)
Anti anaemic drugs (1)
 
Anemia simi joju k.
Anemia simi joju k.Anemia simi joju k.
Anemia simi joju k.
 
Anemia Causes, Types, Symptoms, Diet, and Treatment
Anemia Causes, Types, Symptoms, Diet, and Treatment Anemia Causes, Types, Symptoms, Diet, and Treatment
Anemia Causes, Types, Symptoms, Diet, and Treatment
 
Anemia, Pharmacotherapeutics, PharmD, RGUHS
Anemia, Pharmacotherapeutics, PharmD, RGUHSAnemia, Pharmacotherapeutics, PharmD, RGUHS
Anemia, Pharmacotherapeutics, PharmD, RGUHS
 
Hematopoietic Drugs
Hematopoietic DrugsHematopoietic Drugs
Hematopoietic Drugs
 
HEMATOLOGY AND LYMPHOID SYSTEM
HEMATOLOGY AND LYMPHOID SYSTEMHEMATOLOGY AND LYMPHOID SYSTEM
HEMATOLOGY AND LYMPHOID SYSTEM
 
Hematinics.pptx
Hematinics.pptxHematinics.pptx
Hematinics.pptx
 
Irion defitient and megaloblastic anemias
Irion defitient and megaloblastic anemiasIrion defitient and megaloblastic anemias
Irion defitient and megaloblastic anemias
 
HAEMATINICS
HAEMATINICSHAEMATINICS
HAEMATINICS
 
Pharmacology anemia and its treatment
Pharmacology   anemia and its treatmentPharmacology   anemia and its treatment
Pharmacology anemia and its treatment
 
Heamatinics
HeamatinicsHeamatinics
Heamatinics
 
Megaloblastic Anaemia - Vit B12 deficiency
Megaloblastic Anaemia - Vit B12 deficiencyMegaloblastic Anaemia - Vit B12 deficiency
Megaloblastic Anaemia - Vit B12 deficiency
 
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdfAgents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
Agents for anemia .CXVVVVVVVVVVVVVVVVVVVVVVVVVVVVVpdf
 
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptxANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
 
Anti-Anemic Drugs, (Hematinic) by Baqir Naqvi.pptx
Anti-Anemic Drugs, (Hematinic) by Baqir Naqvi.pptxAnti-Anemic Drugs, (Hematinic) by Baqir Naqvi.pptx
Anti-Anemic Drugs, (Hematinic) by Baqir Naqvi.pptx
 
Final anemia
Final anemiaFinal anemia
Final anemia
 

Plus de Joon Jyoti Sahariah

Plus de Joon Jyoti Sahariah (13)

Ppe pictograms..
Ppe pictograms..Ppe pictograms..
Ppe pictograms..
 
Ohsas 18001
Ohsas 18001Ohsas 18001
Ohsas 18001
 
Iso 14001
Iso 14001Iso 14001
Iso 14001
 
Fire hazard
Fire hazardFire hazard
Fire hazard
 
Evaporation joon
Evaporation joonEvaporation joon
Evaporation joon
 
Distillation
DistillationDistillation
Distillation
 
Crystalli zation ppt
Crystalli zation pptCrystalli zation ppt
Crystalli zation ppt
 
Green chemistry ppt jon
Green chemistry ppt jonGreen chemistry ppt jon
Green chemistry ppt jon
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screening
 
Pharmacophore mapping joon
Pharmacophore mapping joonPharmacophore mapping joon
Pharmacophore mapping joon
 
Postaglandines
PostaglandinesPostaglandines
Postaglandines
 
Immunostimulants
ImmunostimulantsImmunostimulants
Immunostimulants
 

Dernier

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Dernier (20)

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 

Hematinics

  • 1. Name: Jon Jyoti Sahariah B.Pharm 6th Sem Roll No: 05 Year: 2017 Department of Pharmaceutical Sciences Dibrugarh university
  • 2. General term for those nutrients, including iron, folic acid, and vitamin B12, required for the formation and development of blood cells in bone marrow (the process of haematopoiesis), deficiency of which may result in anaemia. Treatment of anemia Increase the number of RBC or hemoglobin content of RBC or both when there is deficiency
  • 4. Aneamia  Not a single disease  Results from a number of different pathologies  Defined as a reduction from the normal quantity of Hb in blood  WHO defines anemia as Hb levels less than 13 g/dl for males and less than 12 g/dl for females  Low Hb levels results in decreased oxygen carrying capacity of blood  Causes:  Blood loss  Impaired RBC functions due to deficiency
  • 5. Iron As Haematinic Agent  Hematopoiesis  The production of circulating erythrocytes, leukocytes and platelets from undifferentiated stem cells, is called hematopoiesis.  It requires:  Iron –for Hb formation
  • 6. Iron storage  Iron is the integral component of haemoglobin In our body:  66-67% of iron is present in hemoglobin.  3% occurs in myoglobin  1% in enzymes -cytochrome, catalase, peroxidase  25% is stored in form of ferritin and hemosiderin
  • 7. Pharmacokinetics : Absorption:  absorbs 5–10% of iron ingested or about 0.5–1 mg daily.  normally absorbed in the duodenum and proximal jejunum.  absorption increases in response to low iron stores or increased iron requirements. STORAGE  primarily as ferritin, in macrophages in the liver, spleen, and bone, and in parenchymal liver cells. Apoferritin synthesis is regulated by the levels of free iron.  Ferritin is detectable in serum. Since the ferritin present in serum is in equilibrium with storage ferritin in reticuloendothelial tissues, the serum ferritin level can be used to estimate total body iron stores.
  • 8. Transport:  transported in the plasma bound to transferrin, a -globulin that specifically binds two molecules of ferrous iron The transferrin-iron complex enters maturing erythroid cells by a specific receptor mechanism. Transferrin receptors internalize the transferrin-iron complex through the process of receptor-mediated endocytosis.  Increased erythropoiesis is associated with an increase in the number of transferrin receptors on developing erythroid cells. Iron store depletion and iron deficiency anemia are associated with an increased concentration of serum transferrin.
  • 9. ELIMINATION  Small amounts are lost in the feces by exfoliation of intestinal mucosal cells, and trace amounts are excreted in bile, urine, and sweat.
  • 10. Indications of oral iron therapy Prophylactic use : 1) pregnancy- from 4th month to lactation. 2) Menstruation 3) Infancy and childhood 4) Premature babies and babies weaned late 5) Professional blood donors
  • 11.  Therapeutic use : 1) Iron deficiency anemia 2) Iron deficiency anemia due to: - menorrhagia - peptic ulcer - piles - hook worm infestation 3) Malabsorption syndrome 4) Anemia of pregnancy 5) Treatment of severe pernicious anemia
  • 12. Parenteral iron preparations:  Iron dextran is a stable complex of ferric hydroxide and low-molecular-weight dextran containing 50 mg of elemental iron per milliliter of solution. It can be given by deep intramuscular injection or by intravenous infusion, although the intravenous route is used most commonly  Headache, light-headedness, fever, arthralgias, nausea and vomiting, back pain, flushing, urticaria, bronchospasm, and rarely, anaphylaxis and death.  Hypersensitivity reaction to the dextran component. Hypersensitivity reactions may be delayed for 48–72 hours after administration.  Anaphylactic reactions  Iron-sucrose complex and iron sodium gluconate complex only by the intravenous route.
  • 13.  Sources : Yeast, liver, green vegetables, Fruits, nuts and cereals Daily requirements : Adult: 50 mcg / day Pregnant women : 100-200 mcg / day Lactating women : 100-200 mcg / day FOLIC ACID:
  • 14. Pharmacokinetics :  Route : oral , parenteral  Absorption: from proximal jejunum  Excretion: Folates are excreted in the urine and stool and are also destroyed by catabolism  folic acid deficiency and megaloblastic anemia can develop within 1–6 months after the intake of folic acid stops.
  • 15. Pharmacodynamics:  Functions : Tetrahydrofolate cofactors participate in one-carbon transfer reactions 1) DNA synthesis : cofactors for the synthesis of purines and pyrimidines 2) Synthesis of thymidylic acid : Enzyme thymidylate synthase catalyzes the transfer of the one-carbon unit.
  • 16. Causes of folic acid deficiency: A) Nutritional ( major causes) 1) poor intake due to  old age  Starvation  Anorexia 2) gastrointestinal disease  Partial gastrectomy  Coeliac disease  Crohn’s disease B) Poor Utilisation: 1) Physiological  pregnancy  starvation  prematurity 2) Pathological  hemolytic disease with excess RBC formation  malignant disease with increased cell turnover  inflammatory disease
  • 17. C) Malabsorption syndrome D) Antifolate drugs :  anticonvulsants ( phenytoin , primidone )  methotrexate  Pyrimethamine  Trimethoprim  Sulfonamides
  • 18. Effects of folic acid deficiency  Megaloblastic anemia  Neural tube defect ( spina bifida ) in the foetus High-risk patients:  pregnant women  patients with alcohol dependence,  hemolytic anemia  liver disease  certain skin diseases  patients on renal dialysis
  • 19. Indications of folic acid: 1) Treat magaloblastic anemia due to folate deficiency 2) Pregnant women 3) Premature infants 4) Patients with hemolytic anemia 5) Liver disease 6) Chronic skin disease 7) Renal dialysis 8) With anti convulsant drugs
  • 20.  Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin, and primidone, and increase the frequency of seizures in susceptible children
  • 21. Liquid oral preparations and injectables in combination form Given im Dose Therapeutic : 2-5 mg / day Prophylactic : 0.5 mg / day Preparations and doses of folic acid :
  • 22. Vit B12  consists of a porphyrin-like ring with a central cobalt atom attached to a nucleotide.  Deoxyadenosylcobalamin and methylcobalamin are the active forms  The chief dietary source of vitamin B12 is microbially derived vitamin B12 in meat (especially liver), eggs, and dairy products  extrinsic factor
  • 23. Pharmacokinetics  stored, primarily in the liver, with an average adult having a total vitamin B12 storage pool of 3000–5000 mcg  normal daily requirements of vitamin B12 are only about 2 mcg  is absorbed only after it complexes with intrinsic factor, a glycoprotein secreted by the parietal cells of the gastric mucosa  the intrinsic factor-vitamin B12 complex is subsequently absorbed in the distal ileum by a highly specific receptor- mediated transport system.  Nutritional deficiency is rare but may be seen in strict vegetarians after many years without meat, eggs, or dairy products.  vitamin B12 is transported to the various cells of the body bound to a plasma glycoprotein, transcobalamin II  Stored in liver  Excreted through urine
  • 24. Indications of Vit B12 a) Megaloblastic anemia b) Neurologic syndrome associated with cobalamin deficiency c) Pernicious anemia
  • 25.  Vitamin B12 for parenteral injection is available as cyanocobalamin or hydroxocobalamin  Administered im  Initial therapy should consist of 100–1000 mcg of vitamin B12  Maintenance therapy consists of 100–1000 mcg intramuscularly once a month for life  neurologic abnormalities are present, maintenance therapy injections should be given every 1–2 weeks for 6 months before switching to monthly injections  oral doses of 1000 mcg of vitamin B12 daily are usually sufficient to treat patients with pernicious anemia
  • 26. Dose:  In india both oral and injectables vit B12 is available mostly or combination preparation along with other vitamines, with or without iron.
  • 27. 1.Treatment and prophylaxis of vitamin B12 deficiency (megaloblastic anemia) 2. Vit B12 injection in pernicious anemia (condition where Vit B12 is not absorbed from the stomach) Uses of vitamin B12